Prehabilitation before surgery for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether a structured exercise program before surgery helps improve recovery after converting unresectable liver cancer to a resectable state. If you are scheduled for conversion therapy, this program may strengthen your body for a smoother postoperative recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with hepatocellular carcinoma (a type of liver cancer) that cannot be surgically removed at first, but you are planning to have conversion therapy to make it operable.
- You are in generally good health (classified as ASA III or lower, meaning you have mild to moderate disease but are fit for surgery).
- You can walk for more than 200 meters without stopping and climb two flights of stairs without a break.
- You do not have other types of liver cancer, spread of the cancer to other organs, or another active cancer.
- You are not pregnant or breastfeeding, and you do not have severe heart, lung, kidney, or blood problems that would prevent exercise.
- You are not currently limited by recent fractures or muscle/bone conditions that would make exercise unsafe.
- You are able to understand the study and provide written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a “prehab” program—structured exercise and preparation—can help people keep up function while they are on chemotherapy for colorectal cancer that has spread to the liver. If you can safely exercise, the program may help you tolerate treatment and stay active.
This trial tests whether a program of exercise, nutrition, and psychological support before major cancer surgery can help you recover faster and have fewer complications. It is designed for people who are at higher risk of surgical complications due to other health conditions.
This trial tests giving two immunotherapy drugs directly into the tumor before surgery for liver cancer. It aims to see if this approach can shrink the tumor and improve outcomes for patients who are candidates for surgery.
This study tests whether a personalized preparation program led by nurses before liver cancer surgery helps patients recover better and have fewer complications. The program is designed specifically for people scheduled to have part of their liver removed.
This trial studies a structured exercise and training program before and after liver transplantation to help people recover better. You may be able to benefit if you’re getting an elective liver transplant and can safely participate in the training plan.
This trial looks at how well certain initial treatments (like targeted therapy, immunotherapy, or liver-directed procedures) work in people with liver cancer who have not had surgery yet. It aims to see if these treatments can shrink the tumor enough to allow removal later.
Hear when a new Advanced Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.